Skandinaviska Enskilda Banken (SEB)
MYGN icon

Skandinaviska Enskilda Banken (SEB)’s Myriad Genetics MYGN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-108,100
Closed -$1.23M – 1089
2020
Q2 		$1.23M Buy
108,100
+5,000
+5% +$71K 0.01% 686
2020
Q1 		$1.48M Buy
103,100
+15,300
+17% +$323K 0.01% 557
2019
Q4 		$2.39M Buy
87,800
+7,300
+9% +$201K 0.02% 512
2019
Q3 		$2.31M Sell
80,500
-13,700
-15% -$399K 0.02% 497
2019
Q2 		$2.62M Sell
94,200
-4,500
-5% -$127K 0.02% 439
2019
Q1 		$3.28M Buy
98,700
+6,900
+8% +$210K 0.03% 358
2018
Q4 		$2.67M Buy
91,800
+8,600
+10% +$309K 0.02% 396
2018
Q3 		$3.83M Buy
83,200
+9,900
+14% +$440K 0.03% 348
2018
Q2 		$2.74M Sell
73,300
-20,200
-22% -$682K 0.02% 366
2018
Q1 		$2.76M Sell
93,500
-400
-0.4% -$13.5K 0.03% 314
2017
Q4 		$3.23M Sell
93,900
-46,800
-33% -$1.58M 0.03% 349
2017
Q3 		$5.09M Buy
140,700
+6,300
+5% +$180K 0.05% 286
2017
Q2 		$3.47M Sell
134,400
-51,400
-28% -$1.09M 0.03% 357
2017
Q1 		$3.57M Sell
185,800
-36,300
-16% -$643K 0.04% 342
2016
Q4 		$3.7M Sell
222,100
-20,900
-9% -$378K 0.04% 280
2016
Q3 		$5M Buy
243,000
+62,100
+34% +$1.58M 0.05% 260
2016
Q2 		$5.54M Buy
180,900
+17,800
+11% +$618K 0.06% 227
2016
Q1 		$6.11M Sell
163,100
-24,400
-13% -$919K 0.07% 211
2015
Q4 		$8.09M Buy
+187,500
New +$7.92M 0.1% 148

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s MYGN Position: Q3 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 108,100 shares — an estimated $1.23M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MYGN in Q4 2015 and held it in 19 quarters. The position peaked at $8.09M in Q4 2015. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 108,100 Myriad Genetics shares in Q3 2020, an estimated $1.23M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Myriad Genetics in Q4 2015 and held it in 19 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Myriad Genetics position peaked at $8.09M in Q4 2015.
  • 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2020, filed 12 Nov 2020.